Antibiotics
Catalog | Product Name / CAS / Description | Structure |
---|---|---|
BBF-02586 |
Pristinamycin IIB (21102-49-8) Inquiry |
|
Pristinamycin IIB is an ester peptide antibiotic produced by Str. pristinaespiralis 5647 (NRRL 2958). Activity against gram-positive bacteria. |
||
BBF-02587 |
Prodigiosin (82-89-3) Inquiry |
|
It is an antibiotic produced by Serratia marcescens HY-3 and Ser. marinorubra. It has a broad biological profile with activity against fungi, tumour cell lines and malaria. It also acts as an inducer of p21WAF1/CIP1 expression via transforming growth factor-β receptor pathway, and activates NAG-1 via glycogen synthase kinase-3β. |
||
BBF-02589 |
Pyoluteorin (25683-07-2) Inquiry |
|
Pyoluteorin is an antibiotic produced by Pseudomonas aeruginosa T359 and IFO3455. It has activity against Gram-positive and negative bacteria, mycobacteria and fungi. |
||
BBF-02590 |
Pyrazomycin (30868-30-5) Inquiry |
|
Pyrazomycin is an antibiotic produced by Str. candidus NRRL 3601. In the culture of monolayer cells, the minimum inhibitory concentration of vaccinia virus is 2 μg/mL, which can also inhibit measles and herpes simplex. In mice, intraperitoneal, subcutaneous, oral and skin application can reduce the pathological changes of vaccinia. Pyrazomycin is a competitive inhibitor of pyrimidine nucleoside metabolism. |
||
BBF-02591 |
Pyridomycin (18791-21-4) Inquiry |
|
Pyridomycin is an ester peptide antibiotic produced by Str. pyridomyceticus. It has strong anti-mycobacterial activity and weak anti-gram-negative bacteria activity. |
||
BBF-02595 |
Nebularine (550-33-4) Inquiry |
|
Nebularine is originally isolated from Agaricus nebularis. Shown to have inhibitory effects against mouse Sarcoma 180 and mycobacteria. |
||
BBF-02596 |
Neoantimycin (22862-63-1) Inquiry |
|
A rare and unusual ring-extended member of the antimycin class; produced by a streptomyces species unrelated to antimycin-producing strains; a selective GRP78 molecular chaperone down-regulator highlights the potential of this class as research probes. |
||
BBF-02597 |
Neoaureothin (59795-94-7) Inquiry |
|
Neoaureothin is a metabolite produced by Streptomyces. It acts as an androgen receptor (AR) antagonist that inhibits binding of dihydrotestosterone (DHT) to ARs and inhibits DHT-induced expression of prostate-specific antigen in LNCaP cells (IC50 = 1.75 nM). |
||
BBF-02599 |
Neomycin Sulfate EP Impurity A (Neamine) (3947-65-7) Inquiry |
|
Neamine, also known as Neomycin A, is a broad-spectrum aminoglycoside antibiotic derived from the neomycin complex produced by the actinomycete S. fradiae. It is a degradation product of neomycin and has potent antibacterial, antitumor, and neuroprotective activities. Neamine is an anti-angiogenesis agent that targets angiogenin and has been shown to inhibit ANG-mediated AsPC-1 cell proliferation in a dose-dependent manner in vitro. In vivo, Neamine has demonstrated anti-tumor effects on AsPC-1 xenograft models, reducing the expression levels of ANG, Ki-67, and CD31 in tumor xenografts. |
||
BBF-02600 |
Neplanocin A (72877-50-0) Inquiry |
|
(−)-Neplanocin A potently and irreversibly inactivates SAH hydrolase (Ki = 8.39 nM). It has antitumor activity against mouse leukemia L1210 cells and broad-spectrum antiviral activity. Neplanocin A is more potent against vesicular stomatitis than the reversible SAH hydrolase inhibitor 3-deazaneplanocin (ID50 = 0.07 and 0.3 μg/ml, respectively). |
||
BBF-02601 | ||
Netropsin is isolated from Streptomyces netropsis as a basic polypeptide. It can specific bind to A-T areas of DNA that is very useful to genetic research. Netropsin can disrupt the cell cycle, prolonging G and arresting in G. Netropsin has antibiotic and antiviral activity. It has been shown that Netropsin is active against Gram-positive and Gram-negative bacteria. |
||
BBF-02602 |
Neutramycin (1404-08-6) Inquiry |
|
It is produced by the strain of Str. rimosus NRRL 3016. Neutramycin is resistant to gram-positive bacteria. |
||
BBF-02603 | ||
Nidulal is originally isolated from Nidula candida 87220. Nidulal induces differentiation of human promyelocytic leukemia cells. In COS-7 cells it selectively activates AP-1 dependent signal transduction in a manner which is similar to TPA/PMA. |
||
BBF-02604 |
Nornidulin (33403-37-1) Inquiry |
|
A depsidone produced by several fungal species; has potent and selective antibacterial activity; has potential as an anti-inflammatory agent. |
||
BBF-02605 | ||
Nigericin, derived from S. hygroscopicus, is an antibiotic potassium ionophore. It exchanges K+ for H+ across biological membranes. Nigericin can be a NLRP3 activator that induces the release of IL-1β as a NALP3-dependent manner. Nigericin triggers eryptosis, an effect paralleled by ROS formation, and in part due to induction of oxidative stress. Nigericin triggers apoptosis. |
||
BBF-02606 |
Nocardamine (26605-16-3) Inquiry |
|
Nocardamine, derived from Nocardia sp., has anti-mycobacterium activity. |
||
BBF-02607 |
Nocardicin A (39391-39-4) Inquiry |
|
Nocardicin A is originally isolated from Nocardia uniformis subsp. tsugamanensis. Nocardicin A has antibacterial action, but it only has strong antibacterial activity against Octococcus, Proteus and Shigella soontii. |
||
BBF-02608 | ||
The smallest member of the macrotetrolide complex produced by a range of streptomyces species; a monovalent cation ionophore with high selectivity for ammonium and potassium. It is resistant to gram-positive bacteria, mycobacteria and fungi, and it also inhibits L cells. |
||
BBF-02609 | ||
A member of the macrotetrolide complex produced by a range of streptomyces species; a monovalent cation ionophore with high selectivity for ammonium and potassium; inhibits T-cell proliferation induced by IL-2 and cytokine production at nanomolar levels for IL-2, IL-4, IL-5 and IFN-γ. It is also resistant to gram-positive bacteria and mycobacteria. |
||
BBF-02610 | ||
A member of the macrotetrolide complex produced by a range of streptomyces species; a monovalent cation ionophore with high selectivity for ammonium and potassium; inhibits T-cell proliferation induced by IL-2 and cytokine production at nanomolar levels for IL-2, IL-4, IL-5 and interferon-γ. It is also resistant to gram-positive bacteria and mycobacteria. |